AARTI DRUGS
Back to All Ratios
|
AARTI DRUGS Last 5 Year EV/CE History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EV/CE(x) | 1.54 | 2.03 | 3.86 | 0.98 | 1.38 |
What is the latest EV/CE ratio of AARTI DRUGS ?
Year | EV/CE |
---|---|
Mar2023 | 1.54 |
Mar2022 | 2.03 |
Mar2021 | 3.86 |
Mar2020 | 0.98 |
Mar2019 | 1.38 |
How is EV/CE of AARTI DRUGS Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2023 | 1.54 | -24.14 | |
Mar2022 | 2.03 | -47.41 | |
Mar2021 | 3.86 | 293.88 | |
Mar2020 | 0.98 | -28.99 | |
Mar2019 | 1.38 | - |
Other Financial Ratios of AARTI DRUGS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,607.4 Cr | -0.5% | 9.6% | 18.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -0.5% |
9.6% |
18.8% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses